Trial intelligence / Profile preview

Finasteride and hydroxychloroquine for frontal fibrosing alopecia

IRCT20210513051276N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of finasteride and hydroxychloroquine in frontal fibrosing alopecia (FFA), sponsored by Isfahan University of Medical Sciences. Started Jun 2021; status: completed.

02

Drugs

finasteridehydroxychloroquine
03

Conditions

frontal fibrosing alopecia (FFA)

Beyond the preview

Go deeper on IRCT20210513051276N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210513051276N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call